Taiho Ventures

Portfolio

The companies we back.

A focused set of biotech ventures spanning oncology and adjacent frontiers — backed from discovery into the clinic.

Portfolio

Our focus shows in who we back.

Every company we've backed since 2016, spanning oncology and the areas around it. Filter by stage to see where each stands today.

No companies match that filter.

Behind the roster

The mandate is narrow on purpose.

We invest from preclinical through proof of concept, across oncology, immunology and allergy, urology, bone and muscle, and orphan disease — in small molecules and biologics, with gene and cell therapy taken opportunistically.

See the investment mandate